U.S. Markets closed

Hospira, Q Core Medical sign international distribution agreement

Hospira announced that the companies have entered into a distribution agreement for the Q Core Sapphire multi-therapy infusion system. Through the arrangement, Hospira will have exclusive rights to market and distribute Sapphire -- a compact and lightweight infusion device system frequently used in ambulatory and hospital settings -- in more than 60 key markets across Europe, Asia and The Americas. The agreement also enables Hospira to collaborate with Q Core for distribution of its product development pipeline.